Literature DB >> 27320470

Mistrust of Pediatric Sickle Cell Disease Clinical Trials Research.

Evelyn M Stevens1, Chavis A Patterson2, Yimei B Li2, Kim Smith-Whitley2, Lamia P Barakat2.   

Abstract

INTRODUCTION: Sickle cell disease (SCD) research is hampered by disparities in participation due in part to mistrust of research among racial/ethnic minorities. Beyond the historic context of research misconduct, little is known about the associations of social ecologic factors with mistrust and of mistrust with SCD clinical trials enrollment. This study evaluated proximal (age, gender, disease severity, perceived stress, SES) and distal (religious beliefs, social support, instrumental support) factors related to mistrust of research among caregivers of children with SCD and adolescents and young adults (AYAs) with SCD.
METHODS: Over an 18-month period (2009-2010), participants completed questionnaires of perceived barriers and benefits to clinical trials enrollment, perceived stress, and self-reported demographic and disease-related information. Analyses (January-June 2015) used multivariable linear regressions to evaluate predictors of mistrust.
RESULTS: Data were analyzed for 154 caregivers (mean age, 38.75 years; SD=9.56 years; 90.30% female) and 88 AYAs (mean age, 24.76 years; SD=7.25 years; 46.40% female). Among caregivers (full model, R(2)=0.14, p≤0.001), greater mistrust was explained by higher perceived stress (β=0.04, p=0.052); religious beliefs (β=0.61, p≤0.001); and greater instrumental support (β=0.07, p=0.044). Among AYAs (full model, R(2)=0.18, p≤0.001), higher mistrust was explained by being male (β=-0.56, p≤0.001) and lower instrumental support (β=-0.11, p=0.016). Mistrust was significantly greater among caregivers that reported no prior involvement in medical research (p=0.003).
CONCLUSIONS: By understanding the complexity through which social ecologic factors contribute to mistrust, researchers may create targeted strategies to address mistrust and increase engagement in SCD research for caregivers and AYAs. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27320470      PMCID: PMC4916926          DOI: 10.1016/j.amepre.2016.01.024

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  47 in total

1.  Clinical research trials: factors that influence and hinder participation.

Authors:  Betty M Kennedy; Michael F Burnett
Journal:  J Cult Divers       Date:  2007

2.  Is religiosity related to attitudes toward clinical trials participation?

Authors:  Svetlana Daverio-Zanetti; Kathryn Schultz; Miguel A Martin del Campo; Vanessa Malcarne; Natasha Riley; Georgia Robins Sadler
Journal:  J Cancer Educ       Date:  2015-06       Impact factor: 2.037

3.  Randomization is not associated with socio-economic and demographic factors in a multi-center clinical trial of children with sickle cell anemia.

Authors:  Dionna O Roberts; Brittany Covert; Mark J Rodeghier; Nagina Parmar; Michael R DeBaun; Alexis A Thompson; Robert I Liem
Journal:  Pediatr Blood Cancer       Date:  2014-04-22       Impact factor: 3.167

Review 4.  A brief review of the pathophysiology, associated pain, and psychosocial issues in sickle cell disease.

Authors:  Christopher L Edwards; Mischca T Scales; Charles Loughlin; Gary G Bennett; Shani Harris-Peterson; Laura M De Castro; Elaine Whitworth; Mary Abrams; Miriam Feliu; Stephanie Johnson; Mary Wood; Ojinga Harrison; Alvin Killough
Journal:  Int J Behav Med       Date:  2005

5.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

6.  Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.

Authors:  Nancy A Omondi; Stacy E Stickney Ferguson; Navneet S Majhail; Ellen M Denzen; George R Buchanan; Ann E Haight; Richard J Labotka; J Douglas Rizzo; Elizabeth A Murphy
Journal:  J Pediatr Hematol Oncol       Date:  2013-05       Impact factor: 1.289

7.  Unhealthy interactions: the role of stereotype threat in health disparities.

Authors:  Joshua Aronson; Diana Burgess; Sean M Phelan; Lindsay Juarez
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

8.  Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sickle cell disease.

Authors:  Carlton Haywood; Sophie Lanzkron; Shawn Bediako; John J Strouse; Jennifer Haythornthwaite; C Patrick Carroll; Marie Diener-West; Gladys Onojobi; Mary Catherine Beach
Journal:  J Gen Intern Med       Date:  2014-09-10       Impact factor: 5.128

9.  Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience.

Authors:  Electra D Paskett; Katherine W Reeves; John M McLaughlin; Mira L Katz; Ann Scheck McAlearney; Mack T Ruffin; Chanita Hughes Halbert; Cristina Merete; Faith Davis; Sarah Gehlert
Journal:  Contemp Clin Trials       Date:  2008-07-31       Impact factor: 2.226

Review 10.  Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.

Authors:  Moon S Chen; Primo N Lara; Julie H T Dang; Debora A Paterniti; Karen Kelly
Journal:  Cancer       Date:  2014-04-01       Impact factor: 6.860

View more
  14 in total

1.  iCanCope with Sickle Cell Pain: Design of a randomized controlled trial of a smartphone and web-based pain self-management program for youth with sickle cell disease.

Authors:  Tonya M Palermo; William T Zempsky; Carlton D Dampier; Chitra Lalloo; Amos S Hundert; Lexa K Murphy; Nitya Bakshi; Jennifer N Stinson
Journal:  Contemp Clin Trials       Date:  2018-10-11       Impact factor: 2.226

2.  Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.

Authors:  Jason R Hodges; Shannon M Phillips; Sarah Norell; Chinonyelum Nwosu; Hamda Khan; Lingzi Luo; Sherif M Badawy; Allison King; Paula Tanabe; Marsha Treadwell; Lucia Rojas Smith; Cecelia Calhoun; Jane S Hankins; Jerlym Porter
Journal:  Blood Adv       Date:  2020-09-22

3.  Process and strategies for patient engagement and outreach in the Sickle Cell Disease (SCD) community to promote clinical trial participation.

Authors:  C Byrnes; M Botello-Harbaum; T Clemons; L Bailey; K M Valdes; V H Coleman-Cowger
Journal:  J Natl Med Assoc       Date:  2022-01-31       Impact factor: 1.798

4.  Medical Mistrust in Black Breast Cancer Patients: Acknowledging the Roles of the Trustor and the Trustee.

Authors:  Arnethea L Sutton; Jun He; Megan C Edmonds; Vanessa B Sheppard
Journal:  J Cancer Educ       Date:  2019-06       Impact factor: 2.037

5.  Evaluation of the Pediatric Research Participation Questionnaire for Measuring Attitudes Toward Cancer Clinical Trials Among Adolescents and Young Adults.

Authors:  Lamia P Barakat; Evelyn Stevens; Yimei Li; Anne Reilly; Janet A Deatrick; Naomi E Goldstein; Lisa A Schwartz
Journal:  J Adolesc Young Adult Oncol       Date:  2019-04-26       Impact factor: 2.223

Review 6.  Genetic therapies for the first molecular disease.

Authors:  Phillip A Doerfler; Akshay Sharma; Jerlym S Porter; Yan Zheng; John F Tisdale; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

7.  Bright IDEAS problem-solving skills training for caregivers of children with sickle cell disease: A two-site pilot feasibility trial.

Authors:  Melissa Young; Megan Voll; Robert B Noll; Diane L Fairclough; Cate Flanagan-Priore
Journal:  Pediatr Blood Cancer       Date:  2020-12-23       Impact factor: 3.167

8.  Increased theta band EEG power in sickle cell disease patients.

Authors:  Michelle Case; Sina Shirinpour; Huishi Zhang; Yvonne H Datta; Stephen C Nelson; Karim T Sadak; Kalpna Gupta; Bin He
Journal:  J Pain Res       Date:  2017-12-27       Impact factor: 3.133

9.  Special considerations in conducting clinical trials of chronic pain management interventions in children and adolescents and their families.

Authors:  Tonya M Palermo; Susmita Kashikar-Zuck; Stefan J Friedrichsdorf; Scott W Powers
Journal:  Pain Rep       Date:  2018-04-10

10.  Motivations and Decision-Making of Adult Sickle Cell Patients in High-Risk Clinical Research.

Authors:  Hae Lin Cho; Scott Y H Kim; Courtney Fitzhugh; Matthew Hsieh; John Tisdale; Christine Grady
Journal:  Biol Blood Marrow Transplant       Date:  2020-03-19       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.